Clinical Trial Update: Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ticagrelor with eptifibatide given as a bolus-only regimen versus a bolus plus abbreviated infusion in acute coronary syndrome; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• EPTIFIBATIDE (EPTIFIBATIDE)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-02-28